271 related articles for article (PubMed ID: 27535017)
1. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
[TBL] [Abstract][Full Text] [Related]
2. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
[TBL] [Abstract][Full Text] [Related]
3. In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
Mortelé O; Vervliet P; Gys C; Degreef M; Cuykx M; Maudens K; Covaci A; van Nuijs ALN; Lai FY
J Pharm Biomed Anal; 2018 May; 153():158-167. PubMed ID: 29494888
[TBL] [Abstract][Full Text] [Related]
4. Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism.
Kintz P; Richeval C; Jamey C; Ameline A; Allorge D; Gaulier JM; Raul JS
Drug Test Anal; 2017 Jul; 9(7):1026-1033. PubMed ID: 27671107
[TBL] [Abstract][Full Text] [Related]
5. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics.
Moosmann B; Bisel P; Auwärter V
Drug Test Anal; 2014; 6(7-8):757-63. PubMed ID: 24604775
[TBL] [Abstract][Full Text] [Related]
7. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples.
Noble C; Mardal M; Bjerre Holm N; Stybe Johansen S; Linnet K
Drug Test Anal; 2017 Aug; 9(8):1182-1191. PubMed ID: 27935260
[TBL] [Abstract][Full Text] [Related]
9. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
Grafinger KE; Hädener M; König S; Weinmann W
Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
[TBL] [Abstract][Full Text] [Related]
10. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
[TBL] [Abstract][Full Text] [Related]
11. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
[TBL] [Abstract][Full Text] [Related]
12. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics.
Moosmann B; Huppertz LM; Hutter M; Buchwald A; Ferlaino S; Auwärter V
J Mass Spectrom; 2013 Nov; 48(11):1150-9. PubMed ID: 24259203
[TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.
Mardal M; Gracia-Lor E; Leibnitz S; Castiglioni S; Meyer MR
Drug Test Anal; 2016 Oct; 8(10):1039-1048. PubMed ID: 26810883
[TBL] [Abstract][Full Text] [Related]
14. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
Pettersson Bergstrand M; Helander A; Hansson T; Beck O
Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism studies on mephedrone and analysis of forensic cases.
Pedersen AJ; Reitzel LA; Johansen SS; Linnet K
Drug Test Anal; 2013 Jun; 5(6):430-8. PubMed ID: 22573603
[TBL] [Abstract][Full Text] [Related]
17. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
18. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
19. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
Meyer MR; Vollmar C; Schwaninger AE; Wolf E; Maurer HH
J Mass Spectrom; 2012 Feb; 47(2):253-62. PubMed ID: 22359337
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.
Temporal KH; Scott KS; Mohr ALA; Logan BK
J Anal Toxicol; 2017 Sep; 41(7):646-657. PubMed ID: 28472358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
